LSA
BIO icon

Leonteq Securities AG’s Bio-Rad Laboratories Class A BIO Stock Holding History

Leonteq Securities AG’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61
Closed -$18.5K – 1313
2025
Q4 		$18.5K Sell
61
-282
-82% -$88K ﹤0.01% 1111
2025
Q3 		$96.2K Buy
343
+146
+74% +$39.7K ﹤0.01% 756
2025
Q2 		$47.5K Sell
197
-120
-38% -$28.4K ﹤0.01% 861
2025
Q1 		$77.3K Sell
317
-1
-0.3% -$301 ﹤0.01% 762
2024
Q4 		$104K Buy
+318
New +$108K 0.01% 674
2023
Q3 		– Sell
-70
Closed -$26.5K – 1205
2023
Q2 		$26.5K Hold
70
– – ﹤0.01% 934
2023
Q1 		$33.5K Buy
70
+34
+94% +$15.9K ﹤0.01% 875
2022
Q4 		$15.1K Buy
+36
New +$14.5K ﹤0.01% 1003
2022
Q3 		– Sell
-300
Closed -$149K – 1290
2022
Q2 		$149K Sell
300
-90
-23% -$46.9K 0.01% 604
2022
Q1 		$220K Sell
390
-60
-13% -$36.2K 0.01% 573
2021
Q4 		$340K Buy
450
+240
+114% +$180K 0.01% 523
2021
Q3 		$157K Sell
210
-15
-7% -$11.2K 0.01% 637
2021
Q2 		$145K Sell
225
-35
-13% -$21.3K 0.01% 639
2021
Q1 		$149K Buy
+260
New +$154K 0.01% 599

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Leonteq Securities AG's BIO Position: Q1 2026 in Review

Leonteq Securities AG sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 61 shares — an estimated $18.5K sold.

Leonteq Securities AG first reported a position in BIO in Q1 2021 and held it in 14 quarters. The position peaked at $340K in Q4 2021. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Leonteq Securities AG reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 61 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $18.5K.
  • Leonteq Securities AG first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and held it in 14 quarters.
  • Leonteq Securities AG's Bio-Rad Laboratories Class A position peaked at $340K in Q4 2021.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.